Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase - PubMed (original) (raw)
Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase
Mathieu Gigoux et al. Proc Natl Acad Sci U S A. 2009.
Abstract
The T-cell costimulatory receptors, CD28 and the inducible costimulator (ICOS), are required for the generation of follicular B helper T cells (T(FH)) and germinal center (GC) reaction. A common signal transducer used by CD28 and ICOS is the phosphoinositide 3-kinase (PI3K). Although it is known that CD28-mediated PI3K activation is dispensable for GC reaction, the role of ICOS-driven PI3K signaling has not been defined. We show here that knock-in mice that selectively lost the ability to activate PI3K through ICOS had severe defects in T(FH) generation, GC reaction, antibody class switch, and antibody affinity maturation. In preactivated CD4(+) T cells, ICOS delivered a potent PI3K signal that was critical for the induction of the key T(FH) cytokines, IL-21 and IL-4. Under the same settings, CD28 was unable to activate PI3K but supported a robust secondary expansion of T cells. Thus, our results demonstrate a nonredundant function of ICOS-PI3K pathway in the generation of T(FH) and suggest that CD28 and ICOS play differential roles during a multistep process of T(FH) differentiation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Fig. 1.
Defective AKT and ERK activation by ICOS-YF. CD4+ T blasts were stimulated with antibodies against CD3 and/or ICOS, and the activation of AKT or MAPKs was measured by immunoblotting using phospho-specific antibodies. A representive of three independent experiments is shown.
Fig. 2.
ICOS-YF and KO mice have reduced levels of class-switched immunoglobulins in serum. Sera were obtained from nonimmunized mice of ICOS WT, YF, and KO mice at 8 weeks of age. Concentrations of IgM, G1, G2a, G2c, G3, and A were determined by isotype specific ELISA. Each data point represents a serum Ig level of an individual mouse (n = 10 WT, 14 YF, and 10 KO). *, P < 0.01.
Fig. 3.
ICOS-YF as well as KO mice have severely impaired humoral immune responses in the PP. GC B cells and TFH cells in the PP were analyzed by flow cytometry. The (Top) two were gated on B220+ B cells and the (Bottom) two on CD4+ T cells. Numbers represent mean ± SD of data pooled from four mice per genotype.
Fig. 4.
Impaired Ab responses in ICOS-YF and ICOS-KO mice upon immunization. (A) Defective GC reaction. Cryosections of spleens from mice immunized with NP16-CGG/alum 12 days before were stained with PNA. (B) Decreased GC B cells and TFH cells in ICOS-YF and KO mice. Mice were immunized with NP16-CGG/alum, and the splenocytes were analyzed 12 days later. Percentages represent mean ± SD of data from three mice per genotype. A representative of two independent experiments. (C) Impaired class switch. Sera were prepared from immunized mice at day 11 (1°) or day 7 (2°) postinjection, and antigen-specific IgG1 were measured by ELISA using NP33-BSA vs. NP3-BSA. Numbers represent mean ± SD of data from six mice per genotype. A representative of two independent experiments. (D) Defective Ab affinity maturation. Mice were immunized at day 0 and boost injected at day 30. Serum samples were prepared at day 11 after primary injection or day 7 after secondary injection, and the anti-NP IgG1 was measured after differential washes with increasing concentrations of NaSCN solution. Each histogram represents mean ± SD of data from six mice per genotype. A representative of two independent experiments.
Fig. 5.
ICOS-YF and ICOS-KO CD4+ T cells have defects in IL-21 and IL-4 expression. (A) ICOS induces IL-21 and IL-4 in a PI3K-dependent manner. Preactivated CD4+ T cells were restimulated with anti-CD3 plus hamster IgG (H), anti-ICOS (I), or anti-CD28 (28) followed by goat anti-hamster IgG for 6 h without or with LY 294002. The cytokine mRNA levels in the restimulated cells were analyzed by qPCR. A representative of three independent experiments. (B) Abrogation of IL-21 and IL-4 induction in ICOS-YF T cells. Cytokine gene expression was analyzed in WT, YF, and KO T cells as described in A. Each data point represents fold increase over hamster IgG control. Data pooled from six independent experiments (n = 5–6 WT, 2–3 YF, and 2–3 KO). *, P < 0.02.
Similar articles
- The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.
Paulos CM, Carpenito C, Plesa G, Suhoski MM, Varela-Rohena A, Golovina TN, Carroll RG, Riley JL, June CH. Paulos CM, et al. Sci Transl Med. 2010 Oct 27;2(55):55ra78. doi: 10.1126/scitranslmed.3000448. Sci Transl Med. 2010. PMID: 20980695 Free PMC article. - Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation.
Gigoux M, Lovato A, Leconte J, Leung J, Sonenberg N, Suh WK. Gigoux M, et al. Mol Immunol. 2014 May;59(1):46-54. doi: 10.1016/j.molimm.2014.01.008. Epub 2014 Jan 31. Mol Immunol. 2014. PMID: 24486724 - CD28 and CTLA-4 coreceptor expression and signal transduction.
Rudd CE, Taylor A, Schneider H. Rudd CE, et al. Immunol Rev. 2009 May;229(1):12-26. doi: 10.1111/j.1600-065X.2009.00770.x. Immunol Rev. 2009. PMID: 19426212 Free PMC article. Review. - Inducible T-cell co-stimulator: Signaling mechanisms in T follicular helper cells and beyond.
Panneton V, Chang J, Witalis M, Li J, Suh WK. Panneton V, et al. Immunol Rev. 2019 Sep;291(1):91-103. doi: 10.1111/imr.12771. Immunol Rev. 2019. PMID: 31402504 Review.
Cited by
- Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.
Song Y, Li J, Wu Y. Song Y, et al. Signal Transduct Target Ther. 2024 Oct 4;9(1):263. doi: 10.1038/s41392-024-01952-8. Signal Transduct Target Ther. 2024. PMID: 39362875 Free PMC article. Review. - TRAF3 regulates STAT6 activation and T-helper cell differentiation by modulating the phosphatase PTP1B.
Arkee T, Hornick EL, Bishop GA. Arkee T, et al. J Biol Chem. 2024 Sep 2;300(10):107737. doi: 10.1016/j.jbc.2024.107737. Online ahead of print. J Biol Chem. 2024. PMID: 39233229 Free PMC article. - Transcriptional regulation of Tfh dynamics and the formation of immunological synapses.
Kim YJ, Choi J, Choi YS. Kim YJ, et al. Exp Mol Med. 2024 Jun;56(6):1365-1372. doi: 10.1038/s12276-024-01254-7. Epub 2024 Jun 3. Exp Mol Med. 2024. PMID: 38825646 Free PMC article. Review. - Immune checkpoints in rheumatoid arthritis: progress and promise.
Small A, Lowe K, Wechalekar MD. Small A, et al. Front Immunol. 2023 Nov 24;14:1285554. doi: 10.3389/fimmu.2023.1285554. eCollection 2023. Front Immunol. 2023. PMID: 38077329 Free PMC article. Review. - The differentiation courses of the Tfh cells: a new perspective on autoimmune disease pathogenesis and treatment.
Yang Q, Zhang F, Chen H, Hu Y, Yang N, Yang W, Wang J, Yang Y, Xu R, Xu C. Yang Q, et al. Biosci Rep. 2024 Jan 31;44(1):BSR20231723. doi: 10.1042/BSR20231723. Biosci Rep. 2024. PMID: 38051200 Free PMC article. Review.
References
- Vinuesa CG, Tangye SG, Moser B, Mackay CR. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol. 2005;5:853–865. - PubMed
- Yu D, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31:357–468. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous